Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
International Journal of Radiation Biology
|
August 18, 2000
Exposure of human osteosarcoma and bone marrow cells to tumour-targeted alpha-particles and gamma-irradiation: analysis of cell survival and microdosimetry
E Aurlien, R H Larsen, G Akabani, et al.
IEEE Transactions on Medical Imaging
|
July 14, 2005
Molecular imaging of small animals with a triple-head SPECT system using pinhole collimation
S D Metzler, R J Jaszczak, N H Patil, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 16, 1999
Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysis
R E McLendon, G E Archer, R H Larsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 26, 1998
Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors
C J Marriott, W Thorstad, G Akabani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 21, 1999
Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors
G Akabani, C J Reist, I Cokgor, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1997
Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49
P K Leichner, G Akabani, D Colcher, et al.
Cancer
|
May 4, 2001
Long term response in a patient with neoplastic meningitis secondary to melanoma treated with (131)I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab')(2): a case study
I Cokgor, G Akabani, H S Friedman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2000
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy
G Akabani, I Cokgor, R E Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2000
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas
I Cokgor, G Akabani, C T Kuan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results
D D Bigner, M T Brown, A H Friedman, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
International Journal of Radiation Biology
|
August 18, 2000
Exposure of human osteosarcoma and bone marrow cells to tumour-targeted alpha-particles and gamma-irradiation: analysis of cell survival and microdosimetry
E Aurlien, R H Larsen, G Akabani, et al.
IEEE Transactions on Medical Imaging
|
July 14, 2005
Molecular imaging of small animals with a triple-head SPECT system using pinhole collimation
S D Metzler, R J Jaszczak, N H Patil, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 16, 1999
Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysis
R E McLendon, G E Archer, R H Larsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 26, 1998
Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors
C J Marriott, W Thorstad, G Akabani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 21, 1999
Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors
G Akabani, C J Reist, I Cokgor, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1997
Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49
P K Leichner, G Akabani, D Colcher, et al.
Cancer
|
May 4, 2001
Long term response in a patient with neoplastic meningitis secondary to melanoma treated with (131)I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab')(2): a case study
I Cokgor, G Akabani, H S Friedman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2000
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy
G Akabani, I Cokgor, R E Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2000
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas
I Cokgor, G Akabani, C T Kuan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results
D D Bigner, M T Brown, A H Friedman, et al.
Page
of 2